Viewing Study NCT00327327


Ignite Creation Date: 2025-12-25 @ 5:06 AM
Ignite Modification Date: 2025-12-26 @ 4:09 AM
Study NCT ID: NCT00327327
Status: COMPLETED
Last Update Posted: 2010-09-15
First Post: 2006-05-17
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Safety Study of Imexon Plus Gemcitabine in Untreated Pancreatic Adenocarcinoma
Sponsor: AmpliMed Corporation
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module